This information is accurate as of 04/6/2026. Please refer back to the website to ensure all reference information is current and up-to-date.

NIP: Adult pneumococcal vaccination – Program advice for health professionals

June 4, 2026
|In Show all, External News
|By Alice Black

From 1 July 2027, Capvaxive will replace Prevenar 13 and Pneumovax 23 on the National Immunisation Program (NIP) for adults. 

Capvaxive will be recommended and funded for: 

  • at-risk adults from 18 years with a specific medical condition 
  • First Nations adults from 25 years 
  • non-Indigenous adults without a risk condition from 65 years. 

Read more at NIP: Adult pneumococcal vaccination – Program advice for health professionals. 

MVEC: Pneumococcal 

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

About MVEC

The Melbourne Vaccine Education Centre (MVEC) is an educational website, developed with the aim of providing up-to-date immunisation information for both healthcare professionals and members of the public. We are based at Murdoch Children’s Research Institute (MCRI), a research organisation, and are affiliated with SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), the Victorian Vaccine Safety Service.

Latest news

June 4, 2026

NIP: Adult pneumococcal vaccination – Program advice for health professionals
June 4, 2026

Immunisation Coalition: Vale: Prof Allan Cripps memorial tribute webinar on pneumococcal disease
Share This